FUSION BIOPSY MARKET Size and trends

Fusion Biopsy Market Size and Trends

The Global Fusion Biopsy Market is estimated to be valued at USD 791.1 Mn in 2025 and is expected to reach USD 1,418.2 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Key Takeaways of the Fusion Biopsy Market:

• By biopsy route, the transrectal segment is expected to contribute the highest share of the market with 53.1% in 2025.
• By product, the equipment segment is expected to contribute the highest share of the market with 53.2% in 2025.
• By application, the prostate cancer segment is expected to contribute the highest share of the market with 80.2% in 2025.
• North America is expected to top the global market with 38.3% share, followed by Asia Pacific with 27.7% share in 2025.

Market Overview:

Advancements in biopsy devices and growing preference for minimally invasive procedures is expected to fuel the market growth during the forecast period. The market is witnessing positive trends with increasing adoption of fusion biopsy globally. Fusion biopsy helps overcome the issues with traditional biopsy methods by combining Magnetic Resonance Imaging (MRI) and ultrasound images to guide the biopsy needle to the suspected area, improving accuracy and maximizing tissue yields. As fusion biopsy provides real-time images to guide needle placement, it enables efficient sampling of tissues while reducing damage to nearby healthy tissues. This trend is expected to drive the demand for fusion biopsy devices.